市場調查報告書
商品編碼
1008114

奈米醫藥的全球市場(2020年∼2026年)

Global Nanomedicines Market 2020-2026

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

奈米技術涉及用於藥物管理的奈米級大型結構和化學品的小型化。在預測期內(2021-2027年),全球奈米藥物市場預計將以11.1%的適度年複合成長率成長。推動市場成長的主要因素包括藥物奈米技術的各種創新,以及心血管疾病、神經系統疾病、傳染病、腫瘤疾病、骨科疾病等各種疾病的患病率上升。預計奈米機器人的發展以及政府的支持將進一步推動市場在預測期內的成長。

本報告提供奈米醫藥的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各適應症類型、用途、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 有競爭力的儀表板
  • 重要的策略分析
  • 主要企業分析
    • 3M Co.
    • Johnson&Johnson Services Inc.
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Eli Lily & Co.

第4章 市場決策要素

  • 動機
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 各適應症類型
    • 心血管疾病
    • 神經疾病
    • 感染疾病
    • 腫瘤性疾病
    • 整形外科疾病
    • 其他(泌尿系統疾病,眼科疾病)
  • 各用途
    • 藥物輸送
    • 主動式植入
    • 疫苗
    • 影像診斷
    • 生物材料
    • 再生醫療
    • 其他(組織再生)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Affymetrix Inc.
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Co.
  • Celgene Corp.
  • CytImmune Sciences Inc.
  • Ferro Corp.
  • GE Global Research
  • Gilead Sciences Inc.
  • Luminex Corp.
  • Nanobiotix SA
  • PerkinElmer Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Shimadzu Co. Ltd
  • Smith & Nephew Plc
  • St. Jude Medical Inc.
  • Starpharma Holdings Ltd.
  • Stryker Corp.
  • Taiwan Liposome Co. Ltd.
  • UCB SA
目錄
Product Code: OMR2023407

Global Nanomedicines Market Size, Share & Trends Analysis Report By Indication Type (Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Oncological Diseases, Orthopedic Diseases, and Other Diseases (Urological Disease, Ophthalmic Diseases)), and by Application (Drug Delivery, Active Implants, Vaccines, Diagnostic Imaging, Biomaterials, Regenerative Medicines, and Other Applications (Tissue Regeneration)) Forecast, 2021-2027

Nanotechnology involves the miniaturization of larger structures and chemicals at a nanometric scale for drug administration. The global nanomedicines market is projected to grow at a modest CAGR of 11.1% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the various innovations in nanotechnology for medicines along with the rise in the prevalence of various diseases such as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopedic diseases, and others. Developments in nanorobotics along with government support are further expected to propel the growth of the market over the forecast period.

The global nanomedicines market is segmented on the basis of indication type and application. Based on the indication type, the market is segmented as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopedic diseases, and others. The other segment includes urological disease and ophthalmic diseases. The cardiovascular diseases segment is likely to hold a substantial share in the market over the forecast period. Based on the applications, the market is segmented as drug delivery, active implants, vaccines, diagnostic imaging, biomaterials, regenerative medicines, and other applications. The other segment includes tissue regeneration. The drug delivery segment is likely to hold a substantial share in the market over the forecast period.

Based on the demographic viewpoint, the market is segmented as North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is projected to hold a significant market share over the forecast period owing to various R&D activities conducted by the key players. Further, 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others are some of the prominent players functioning in the global Nanomedicine market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.

RESEARCH METHODOLOGY

The market study of the global nanomedicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for nanomedicine companies, healthcare companies, research institutes and universities, other related companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Nanomedicine Market Research and Analysis by Indication Type

2. Global Nanomedicine Market Research and Analysis by Applications

The Report covers:

  • Comprehensive research methodology of the global nanomedicine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nanomedicine market.
  • Insights about market determinants which are stimulating the global nanomedicine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. 3M Co.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Johnson & Johnson Services Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Merck & Co. Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Thermo Fisher Scientific Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Eli Lily & Co.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Nanomedicine Market by Indication Type
    • 5.1.1. Cardiovascular Diseases
    • 5.1.2. Neurological Diseases
    • 5.1.3. Infectious Diseases
    • 5.1.4. Oncological Diseases
    • 5.1.5. Orthopedic Diseases
    • 5.1.6. Other Diseases (Urological Disease, Ophthalmic Diseases)
  • 5.2. Global Nanomedicine Market by Application
    • 5.2.1. Drug Delivery
    • 5.2.2. Active Implants
    • 5.2.3. Vaccines
    • 5.2.4. Diagnostic Imaging
    • 5.2.5. Biomaterials
    • 5.2.6. Regenerative Medicines
    • 5.2.7. Other Applications (Tissue Regeneration)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. ASEAN
    • 6.3.5. South Korea
    • 6.3.6. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Affymetrix Inc.
  • 7.2. AstraZeneca Plc.
  • 7.3. Bristol-Myers Squibb Co.
  • 7.4. Celgene Corp.
  • 7.5. CytImmune Sciences Inc.
  • 7.6. Ferro Corp.
  • 7.7. GE Global Research
  • 7.8. Gilead Sciences Inc.
  • 7.9. Luminex Corp.
  • 7.10. Nanobiotix SA
  • 7.11. PerkinElmer Inc.
  • 7.12. Pfizer Inc.
  • 7.13. Sanofi SA
  • 7.14. Shimadzu Co. Ltd
  • 7.15. Smith & Nephew Plc
  • 7.16. St. Jude Medical Inc.
  • 7.17. Starpharma Holdings Ltd.
  • 7.18. Stryker Corp.
  • 7.19. Taiwan Liposome Co. Ltd.
  • 7.20. UCB SA

LIST OF TABLES

  • 1. GLOBAL NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL NANOMEDICINES FOR CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL NANOMEDICINES FOR NEUROLOGICAL DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL NANOMEDICINES FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL NANOMEDICINES FOR ONCOLOGICAL DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL NANOMEDICINES FOR ORTHOPEDIC DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL NANOMEDICINES FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 9. GLOBAL NANOMEDICINES FOR DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL NANOMEDICINES FOR ACTIVE IMPLANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL NANOMEDICINES FOR VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL NANOMEDICINES FOR DIAGNOSTIC IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL NANOMEDICINES FOR BIOMATERIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL NANOMEDICINES FOR REGENERATIVE MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL NANOMEDICINES FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 20. EUROPEAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. EUROPEAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027 ($ MILLION)
  • 22. EUROPEAN NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY INDICATION TYPE, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD NANOMEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NANOMEDICINE MARKET SHARE BY INDICATION TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL NANOMEDICINE MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL NANOMEDICINE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. ROE NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. ASEAN NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. SOUTH KOREA NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF ASIA-PACIFIC NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD NANOMEDICINE MARKET SIZE, 2020-2027 ($ MILLION)